Biocompatibles International plc http://www.alacrastore.com/company-snapshot/Biocompatibles_International_plc-2014279 Monday, October 13, 2008 12:45:23 PM 2014279 Biocompatibles International plc en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/hmsc/2880-pdfhmsc/2880-pdfnormHemscott Company Fact Sheets provide business details, share data, valuation metrics, key statistics and dates, progress reports, major shareholders, directors, regulatory news, as well as five-year price charts, trading records and forecasts. 2880Biocompatibles International PLCBiocompatibles International PLC9/17/2008 7:13:00 PM2880-pdfBII136224.00Biocompatibles International PLC: Company Facts Reportfacts2880-pdfCompany Profiles & FinancialsHemscott Company Reportshttp://www.alacrastore.com/storecontent/hmsc/2880-xlshmsc/2880-xlsnorm2880Biocompatibles International PLCBiocompatibles International PLC9/17/2008 7:13:00 PMBII136139.00Biocompatibles International PLC: Company Insight Reportinsight2880-xlsCompany Profiles & FinancialsHemscott Company ReportsUS - Biocompatibles International PLC (BI) planned to acquire BrachySciences, a manufacturer and wholesaler of radioactive seeds, for $##.### mil. The consideration was to consist of $#.# mil in cash, the issuance of #.### mil BI ordinary shares valued at $#.### mil and up to $## mil in profit related payments. The shares were valued based on BI's closing stock price of $#.#### on July ##, the last full trading day prior to the announcement.7/26/2008 9:51:27 AM09058Z10392Y09058Z10392YBiocompatibles International PLCBrachySciencesBiocompatibles International PLCBrachyScienceshttp://www.alacrastore.com/storecontent/Thomson_M%26A/Biocompatibles_Intl_PLC_acquires_BrachySciences-1998993020sdc/19989930201998993020Copyright © 2008, Thomson Financial, All Rights ReservedLondonDrugsUnited KingdomBiological products, except diagnostic substances2836FFForeignPublicBII.L2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizationsMeasuring, Medical, Photo Equipment; ClocksUnited StatesSurgical and medical instruments and apparatus3841CTConnecticutPrivate190560001Biotech coMnfr,whl radioactive seedsCashEarnoutOrdinary ShareAssets1030891001Jul 26 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.00000Biocompatibles InternationalPLC, located in Farnham,Surrey, is a biotechnologycompany in the field ofdrug-device combinationproducts, operating throughthree businesses. TheInternational Divisionconducts the marketing ofBiocompatibles approved Beadproducts, which are sold tohospitals by our distributionpartners, includingAngiodynamics Inc and TerumoCorp. The Drug Delivery andCellMed businesses are engagedin new product development andlicensing. The company wasfounded in 1984.Biocompatibles International PLC, located in Farnham,Surrey, is a biotechnology company in the field ofdrug-device combination products, operating through threebusinesses. The International Division conducts themarketing of Biocompatibles approved Bead products, whichare sold to hospitals by our distribution partners,including Angiodynamics Inc and Terumo Corp. The DrugDelivery and CellMed businesses are engaged in new productdevelopment and licensing. The company was founded in 1984.Biocompatibles International PLC, located in Farnham, Surrey, is a biotechnology company in the field of drug-device combination products, operating through three businesses. The International Division conducts the marketing of Biocompatibles approved Bead products, which are sold to hospitals by our distribution partners, including Angiodynamics Inc and Terumo Corp. The Drug Delivery and CellMed businesses are engaged in new product development and licensing. The company was founded in 1984.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.00000BrachySciences, located inOxford, Connecticut,manufactures and wholesalesradioactive seeds as well asunique delivery systems andancillary equipment used inbrachytherapy implants. Theyalso provide products,technologies and services tothe physicians andinstitutions that treatpatients diagnosed withprostate cancer.BrachySciences, located in Oxford, Connecticut, manufacturesand wholesales radioactive seeds as well as unique deliverysystems and ancillary equipment used in brachytherapyimplants. They also provide products, technologies andservices to the physicians and institutions that treatpatients diagnosed with prostate cancer.BrachySciences, located in Oxford, Connecticut, manufactures and wholesales radioactive seeds as well as unique delivery systems and ancillary equipment used in brachytherapy implants. They also provide products, technologies and services to the physicians and institutions that treat patients diagnosed with prostate cancer.0.000000.000000.000000.00000YU.S. Dollar25 Jul 08Fri, 25 Jul 2008 00:00:00 ESTDate Announced: 07/25/2008Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000021.644 U.S. Dollar21.644000.0000021.644 U.S. Dollar21.644000.000000.000000.000000.0000021.6440021.644 U.S. Dollar1.00000N10.869000.000000.000000.000000.000000.0000021.6440021.644000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.00000US - BiocompatiblesInternational PLC (BI) plannedto acquire BrachySciences, amanufacturer and wholesaler ofradioactive seeds, for $21.644mil. The consideration was toconsist of $6.5 mil in cash,the issuance of 1.133 mil BIordinary shares valued at$3.144 mil and up to $12 milin profit related payments.The shares were valued basedon BI's closing stock price of$2.7756 on July 24, the lastfull trading day prior to theannouncement.US - Biocompatibles International PLC (BI) planned to acquire BrachySciences, a manufacturer and wholesaler of radioactive seeds, for $21.644 mil. The consideration was to consist of $6.5 mil in cash, the issuance of 1.133 mil BI ordinary shares valued at $3.144 mil and up to $12 mil in profit related payments. The shares were valued based on BI's closing stock price of $2.7756 on July 24, the last full trading day prior to the announcement.US - Biocompatibles International PLC (BI) planned to acquire BrachySciences, amanufacturer and wholesaler of radioactive seeds, for $21.644 mil. The consideration wasto consist of $6.5 mil in cash, the issuance of 1.133 mil BI ordinary shares valued at$3.144 mil and up to $12 mil in profit related payments. The shares were valued based onBI's closing stock price of $2.7756 on July 24, the last full trading day prior to theannouncement.US - Biocompatibles International PLC (BI) planned to acquire BrachySciences, a manufacturer and wholesaler of radioactive seeds, for $21.644 mil. The consideration was to consist of $6.5 mil in cash,the issuance of 1.133 mil BI ordinary shares valued at $3.144 mil and up to $12 mil in profit related payments. The shares were valued based on BI's closing stock price of $2.7756 on July 24, the lastfull trading day prior to the announcement.US - Biocompatibles International PLC (BI) planned to acquire BrachySciences, a manufacturer and wholesaler of radioactive seeds, for$21.644 mil. The consideration was to consist of $6.5 mil in cash, the issuance of 1.133 mil BI ordinary shares valued at $3.144 mil andup to $12 mil in profit related payments. The shares were valued based on BI's closing stock price of $2.7756 on July 24, the last fulltrading day prior to the announcement.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002835:In vitro and in vivo diagnostic substances3841:Surgical and medical instruments and apparatus5047:Medical, dental, and hospital equipment & supplies190560001LondonUnited Kingdom2836ForeignPublicBII.L2835:In vitro and in vivo diagnostic substances3841:Surgical and medical instruments and apparatus5047:Medical, dental, and hospital equipment & supplies1030891001United States3841ConnecticutPrivate21.6440021.6440021.6440010.86900Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/bir/480220bir/480220normBiocompatibles International PLCUnited KingdomManufacturing: The company has developed a range of polymers containing phosphorylcholine (PC) which are used in the manufacture of medical devices with improved performance characteristics. PC has a great affinity for water and is able to reduce signific384138513391123391159BEBII5/21/2008 6:25:00 AM480220Company Profiles & FinancialsGale Company Profiles